1. Home
  2. ANIK vs OPRT Comparison

ANIK vs OPRT Comparison

Compare ANIK & OPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anika Therapeutics Inc.

ANIK

Anika Therapeutics Inc.

HOLD

Current Price

$14.42

Market Cap

198.9M

Sector

Health Care

ML Signal

HOLD

Logo Oportun Financial Corporation

OPRT

Oportun Financial Corporation

HOLD

Current Price

$5.16

Market Cap

236.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANIK
OPRT
Founded
1983
2005
Country
United States
United States
Employees
N/A
1578
Industry
Medical/Dental Instruments
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
198.9M
236.0M
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
ANIK
OPRT
Price
$14.42
$5.16
Analyst Decision
Buy
Buy
Analyst Count
1
2
Target Price
$17.00
$7.00
AVG Volume (30 Days)
53.8K
586.1K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
80.16
127.18
EPS
N/A
0.05
Revenue
$112,819,000.00
$956,685,000.00
Revenue This Year
$5.98
$32.79
Revenue Next Year
$7.42
$4.47
P/E Ratio
N/A
$103.20
Revenue Growth
N/A
N/A
52 Week Low
$7.90
$4.03
52 Week High
$16.24
$7.73

Technical Indicators

Market Signals
Indicator
ANIK
OPRT
Relative Strength Index (RSI) 46.27 49.75
Support Level $13.91 $5.06
Resistance Level $15.08 $5.67
Average True Range (ATR) 0.48 0.23
MACD -0.04 0.03
Stochastic Oscillator 46.27 63.75

Price Performance

Historical Comparison
ANIK
OPRT

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.

About OPRT Oportun Financial Corporation

Oportun Financial Corp is engaged in providing financial services to people who either do not have a credit score or who may have a limited credit history. The company offers Personal Loans, Auto Loans, unsecured personal loans, and secured personal loans, and provides deposit accounts, debit card services, and other transaction services to its customers. Its product offerings include small-dollar, unsecured installment loans and other products and services.

Share on Social Networks: